Corporate Profile

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias. Robotic Magnetic Navigation helps physicians provide unsurpassed patient care with improved safety and unmatched catheter precision, reach, and stability. Over 100,000 patients have been treated with Stereotaxis technology at over 100 leading global hospitals.

Investors

Date	Title
03/09/26	Stereotaxis Reports 2025 Full Year Financial Results
02/12/26	Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026
02/09/26	Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program
01/06/26	Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Recent Filings

Filing date	Description	Form
04/03/26	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A
04/03/26	Additional proxy soliciting materials - definitive	DEFA14A
04/03/26	Amendment to a previously filed 10-K	10-K/A
03/20/26	EFFECT	EFFECT

Alert type
Stereotaxis Inc. SEC Filing
Stereotaxis Inc. Press Release Alert

Investors

Corporate Profile

Investors

View All (Press Releases)

View All (Events)

Recent Filings

View All (Recent Fillings)